Vorinostat-induced autophagy switches from a death-promoting to a cytoprotective signal to drive acquired resistance
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Vorinostat-induced autophagy switches from a death-promoting to a cytoprotective signal to drive acquired resistance
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 4, Issue 2, Pages e486-e486
Publisher
Springer Nature
Online
2013-02-07
DOI
10.1038/cddis.2012.210
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Autophagy blockade enhances HDAC inhibitors’ pro-apoptotic effects
- (2011) Gonzalo Lopez et al. Autophagy
- Autophagy: for better or for worse
- (2011) Ellen Wirawan et al. CELL RESEARCH
- HDAC6 α-tubulin deacetylase: A potential therapeutic target in neurodegenerative diseases
- (2011) Guoyi Li et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- A phase 2 study of vorinostat for treatment of relapsed or refractory Hodgkin lymphoma: Southwest Oncology Group Study S0517
- (2011) Mark H. Kirschbaum et al. LEUKEMIA & LYMPHOMA
- Role of AMPK-mTOR-Ulk1/2 in the Regulation of Autophagy: Cross Talk, Shortcuts, and Feedbacks
- (2011) S. Alers et al. MOLECULAR AND CELLULAR BIOLOGY
- Autophagy as a target for anticancer therapy
- (2011) Filip Janku et al. Nature Reviews Clinical Oncology
- Vorinostat Induces Reactive Oxygen Species and DNA Damage in Acute Myeloid Leukemia Cells
- (2011) Luca A. Petruccelli et al. PLoS One
- Autophagic degradation of active caspase-8
- (2010) Wen Hou et al. Autophagy
- Overcoming resistance to histone deacetylase inhibitors in human leukemia with the redox modulating compound -phenylethyl isothiocyanate
- (2010) Y. Hu et al. BLOOD
- Activity of the Novel Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor NVP-BEZ235 against T-Cell Acute Lymphoblastic Leukemia
- (2010) F. Chiarini et al. CANCER RESEARCH
- Selective Autophagy in Cancer Development and Therapy
- (2010) Ivan Dikic et al. CANCER RESEARCH
- Histone Deacetylase Inhibitors in the Treatment of Hematological Malignancies and Solid Tumors
- (2010) Mario Federico et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor
- (2010) Matthew R Janes et al. NATURE MEDICINE
- Inhibition of histone deacetylase overcomes rapamycin-mediated resistance in diffuse large B-cell lymphoma by inhibiting Akt signaling through mTORC2
- (2009) M. Gupta et al. BLOOD
- The histone deacetylase inhibitors LAQ824 and LBH589 do not require death receptor signaling or a functional apoptosome to mediate tumor cell death or therapeutic efficacy
- (2009) L. Ellis et al. BLOOD
- Autophagy inhibition enhances vorinostat-induced apoptosis via ubiquitinated protein accumulation
- (2009) Jennifer S. Carew et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Targeting the phosphoinositide 3-kinase pathway in cancer
- (2009) Pixu Liu et al. NATURE REVIEWS DRUG DISCOVERY
- Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions
- (2009) C. Choudhary et al. SCIENCE
- mTORC1 Phosphorylates the ULK1-mAtg13-FIP200 Autophagy Regulatory Complex
- (2009) E. Y. Chan Science Signaling
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started